How does exercise cause asthma attacks?

Current Opinion in Allergy and Clinical Immunology

Volumn 6, Issue 1, 2006, Pages 37-42

  Anderson, Sandra D ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Airway injury; Bronchoconstriction; Exercise; Mast cells; Mediators

Indexed keywords

ADENOSINE; ARACHIDONATE 5 LIPOXYGENASE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FORMOTEROL; HISTAMINE; LORATADINE; MONTELUKAST; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN; AUTACOID; LEUKOTRIENE E4; PROSTAGLANDIN F2 ALPHA;

AIRWAY; ASTHMA; ATHLETE; BRONCHOSPASM; CELL FUNCTION; DEHYDRATION; DRUG RESPONSE; EPITHELIUM; EPITHELIUM CELL; EVAPORATION; EXERCISE; EXPIRED AIR; HUMAN; MAST CELL; MEDIATOR; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; REVIEW; SPUTUM; STIMULUS; UPREGULATION; EXERCISE INDUCED ASTHMA; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE;

ASTHMA, EXERCISE-INDUCED; BRONCHOCONSTRICTION; DINOPROST; HUMANS; INFLAMMATION MEDIATORS; LEUKOTRIENE E4; MAST CELLS;

EID: 33746718743     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/01.all.0000199797.02423.78     Document Type: Review

References (58)

1. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is. . .. J Allergy Clin Immunol 2000; 106:453-459.
2. Daviskas E, Gonda I, Anderson SD. Local airway heat and water vapour losses. Respir Physiol 1991; 84:115-132.
3. Anderson SD, Daviskas E, Smith CM. Exercise-induced asthma: a difference in opinion regarding the stimulus. Allergy Proc 1989; 10:215-226.
4. Daviskas E, Anderson SD, Gonda I, et al. Changes in mucociliary clearance during and after isocapnic hyperventilation in asthmatic and healthy subjects. Eur Respir J 1995; 8:742-751.
5. Högman M, Hjoberg, Mörk A-C, et al. Dry gas hyperpnea changes airway reactivity and ion content of rabbit tracheal wall. Respir Physiol 1997; 109:65-72.
6. Freed AN, Davis MS. Hyperventilation with dry air increases airway surface fluid osmolality in canine peripheral airways. Am J Respir Crit Care Med 1999; 159:1101-1107.
7. Davis MS, Daviskas E, Anderson SD, et al. Airway surface fluid desiccation during isocapnic hyperpnea. J Appl Physiol 2003; 94:2545-2547.
8. Anderson SD, Kippelen P. Exercise-induced bronchoconstriction: pathogenesis. Curr Allergy Asthma Rep 2005; 5:116-122. Suggests that airway injury and plasma exudation result in alterations in the contractile properties of smooth muscle to cause bronchial hyperresponsiveness and that these events allow circulating mediators to cause EIB.
9. Anderson SD, Daviskas E. Pathophysiology of exercise-induced asthma. In: Weiler J, editor. Allergic and Respiratory Disease in Sports Medicine. New York: Marcel Dekker; 1997. pp. 87-114.
10. Anderson SD, Holzer K. Exercise-induced asthma: Is it the right diagnosis in elite athletes? J Allergy Clin Immunol 2000; 106:419-428.
11. Widdicombe JH. Regulation of the depth and composition of the airway surface liquid. J Anat 2002; 201:313-318.
12. Tarran R, Button B, Picher M, et al. Normal and cystic fibrosis airway surface liquid homeostasis: The effects of phasic shear stress and viral infections. J Biol Chem 2005; 280:35751-35759. Demonstrates release of adenosine in response to shear stress and that this may be the mechanism whereby airway surface liquid is controlled during exercise.
13. Lazarowski ER, Tarran R, Grubb BR, et al. Nucleotide release provides a mechanism for airway surface liquid homeostasis. J Biol Chem 2004; 279:36855-36864.
14. Loomis WH, Namiki S, Ostrom RS, et al. Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation. J Biol Chem 2003; 278:4590-4596.
15. Csoma Z, Huszar E, Vizi E, et al. Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction. Eur Respir J 2005; 25:873-878. First report on finding adenosine in exhaled breath condensate relating to the severity of EIB.
16. Polosa R. Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease. Eur Respir J 2002; 20:488-496.
17. Anderson SD, Brannan JD. Methods for 'indirect' challenge tests including exercise, eucapnic voluntary hyperpnea and hypertonic aerosols. Clin Rev Allergy Immunol 2003; 24:63-90.
18. Hallstrand TS, Moody MW, Wurfel MM, et al. Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2005; 168:1181-1189. This is the first paper to report an increase in concentration of mediators in induced sputum following exercise and the reduction in concentration following treatment with a combination of a histamine and leukotriene receptor antagonist.
19. 1 of < 7% and concludes that airway injury, overexpression of cysteinyl leukotrienes, and an eosinophilia are features of EIB.
20. Persson CGA, Erjefalt JS. Airway epithelial restitution after shedding and denudation. In: Crystal RG, West JB, Barnes PJ, Weibel ER, editors. The Lung, 2nd ed. Philadelphia: Lippencott-Raven; 1997. pp. 2611-2627.
21. Johnson PR, Burgess JK, Underwood PA, et al. Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. J Allergy Clin Immunol 2004; 113:690-696.
22. Sue-Chu M, Larsson L, Moen T, et al. Bronchoscopy and bronchoalveolar lavage findings in cross-country skiers with and without "ski asthma". Eur Respir J 1999; 13:626-632.
23. Berger P, Walls AF, Marthan R, et al. Immunoglobulin E-induced passive sensitization of human airways: an immunohistochemical study. Am J Respir Crit Care Med 1998; 157:610-616.
24. Ammit AJ, Bekir SS, Johnson PR, et al. Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi. Am J Respir Crit Care Med 1997; 155:1123-1129.
25. Koh YI, Choi IS, Lim H. Atopy may be related to exercise-induced bronchospasm in asthma. Clin Exp Allergy 2002; 32:532-536.
26. Kemp JP, Dockhorn RJ, Shapiro GG, et al. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J Pediatr 1998; 133:424-428.
27. Carroll NG, Mutavdzic S, James AL. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J 2002; 19:879-885.
28. Karjalainen E-M, Laitinen A, Sue-Chu M, et al. Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med 2000; 161:2086-2091.
29. Godfrey S. The physiological assessment of the effect of DSCG in the asthmatic child. Respiration 1970; 27 (Suppl):353-356.
30. Finnerty JP, Holgate ST. Evidence for the roles of histamine and prostaglandins asmediators in exercise-induced asthma: the inhibitory effect of terfenadine and flurbiprofen alone and in combination. Eur Respir J 1990; 3:540-547.
31. Shimizu T, Mochizuki H, Shigeta M, et al. Effect of inhaled indomethacin on exercise-induced bronchoconstriction in children with asthma. Am J Respir Crit Care Med 1997; 155:170-173.
32. Rundell K, Spiering BA, Baumann JM, et al. Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise. Br J Sports Med 2005; 39:232-236. Eucapnic voluntary hyperventilation is a very potent stimulus to airway narrowing yet a single dose of 10 mg of montelukast 6 h before challenge provided 53% protection on the maximum fall in FEV1, a value close to the 59% observed using exercise as the provoking stimulus.
33. Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998; 339:147-152.
34. Anderson SD, Brannan JD. Exercise induced asthma: is there still a case for histamine? [editorial] J Allergy Clin Immunol 2002; 109:771-773.
35. 4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997; 52:1030-1035.
36. O'Sullivan S, Roquet A, Dahlén B, et al. Evidence for mast cell activation during exercise-induced bronchoconstriction. Eur Respir J 1998; 12:345-350.
37. Carraro S, Corradi M, Zanconato S, et al. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. J Allergy Clin Immunol 2005; 115:764-770. Reports a significant difference in baseline levels of cysteinyl leukotrienes in asthmatic children with EIB relative to asthmatic children without EIB and relative to control subjects. The measurements were made in exhaled breath condensate.
38. Anderson SD. Single dose agents in the prevention of exercise-induced asthma: a descriptive review. Treat Respir Med 2004; 3:365-379.
39. Jones A. Asymptomatic bronchial hyperreactivity and the development of asthma and other respiratory tract illnesses in children. Thorax 1994; 49:757-761.
40. Posbjerg C, von Listow ML, Ulrik CS, et al. Outcome in adulthood of asymptomatic airway hyperresponsiveness to histamine and exercise-induced bronchospasm in childhood. Ann Allergy Asthma Immunol 2005; 95:137-142. The finding that 30% of children with asympomatic EIB in childhood go on to develop asthma in adulthood. This may encourage early treatment of EIB.
41. Mickleborough TD, Murray RL, Ionescu AA, et al. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003; 168:1181-1189.
42. Caillaud C, Le Creff C, Legros P, et al. Strenuous exercise increases plasmatic and urinary leukotriene E4 in cyclists. Can J Appl Physiol 2003; 28:793-806.
43. Hilberg T, Deigner HP, Moller E, et al. Transcription in response to physical stress-clues to the molecular mechanisms of exercise-induced asthma. Faseb J 2005; 19:1492-1494. First paper to describe upregulation of genes coding the 5-lipoxygenase pathway in response to exercise in healthy nonasthmatics and serves to confirm the potential for cysteinyl leukotrienes to be important in the pathogenesis of EIB.
44. Brannan JD, Gulliksson M, Anderson SD, et al. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 2003; 22:491-496.
45. Mai XM, Bottcher F, Bruhammar M, et al. Urinary inflammatory mediators and inhalation of hypertonic saline in children. Allergy 2005; 60:60-64. Reports for the first time that healthy nonasthmatic children can also have a significant increase in urinary excretion of leukotriene E4 in response to a surrogate osmotic stimulus (4.5% saline).
46. Brannan JD, Gulliksson M, Anderson SD, et al. Eformoterol fumarate & sodium cromoglycate (SCG) inhibit the airway response to inhaled mannitol in asthmatics by mast cell inhibition. J Allergy Clin Immunol 2004; 113 (Suppl 1):S190.
47. Gulliksson M, Brannan JD, Anderson SD, et al. Inhibition of the airway response to mannitol with either eformoterol or sodium cromoglycate (SCG) does not alter leukotriene release in asthmatic subjects. Eur Respir J 2004; 24 (Suppl 48):443s.
48. Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 1987; 90:421-429.
49. Scola AM, Chong LK, Suvarna SK, et al. Desensitisation of mast cell β2-adrenoceptor-mediated responses by salmeterol and formoterol. Br J Pharmacol 2004; 141:163-171.
50. Brightling CE, Bradding P, Symon FA, et al. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346:1699-1705.
51. O'Byrne PM. Leukotrienes in the pathogenesis of asthma. Chest 1997; 111 (Suppl 2):27S-34S.
52. Greiff L, Andersson M, Coman WB, et al. Challenge-induced plasma exudation and mucinous secretion in human airways. Clin Physiol Funct Imaging 2005; 25:241-245. Reports that plasma exudation, as demonstrated by an increase in α-macroglobulin in nasal fluid, occurs in healthy nonasthmatic people when histamine is used as the stimulus.
53. Greiff L, Andersson M, Wollmer P, et al. Hypertonic saline increases secretory and exudative responsiveness of human nasal airway in vivo. Eur Respir J 2003; 21:308-312.
54. Forsythe P, McGarvey LP, Heaney LG, et al. Sensory neuropeptides induce histamine release from bronchoalveolar lavage cells in both nonasthmatic coughers and cough variant asthmatics. Clin Exp Allergy 2000; 30: 225-232.
55. Togias AG, Proud D, Lichenstein LM, et al. The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air. Am Rev Respir Dis 1988; 137:625-629.
56. Eggleston PA, Kagey-Sobotka A, Schleimer RP, et al. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis 1984; 130:86-91.
57. Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol 1995; 95:29-33.
58. Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992; 90:32-42.